Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated

G F Baxter1, M M Mocanu, B K Brar

  • 1The Hatter Institute, University College, Grafton Way, London WC1E 6DB, U.K. hatter-institute@ucl.ac.uk

Insights

Transforming growth factor-beta1 (TGF-beta1) reduces heart cell death during reperfusion injury. This protection against apoptosis and infarct size is mediated by p42/p44 mitogen-activated protein kinase (MAPK) signaling.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Molecular Medicine

Background:

  • Myocardial ischemia-reperfusion injury involves significant apoptosis, or programmed cell death.
  • Growth factors can promote cell survival and counteract apoptosis.
  • Transforming growth factor-beta1 (TGF-beta1) is a key growth factor implicated in cellular responses.

Purpose of the Study:

  • To investigate the protective effects of TGF-beta1 against reperfusion-induced apoptosis in cardiac myocytes.
  • To determine the role of p42/p44 mitogen-activated protein kinase (MAPK) signaling in TGF-beta1's protective mechanism.

Main Methods:

  • Rat ventricular myocytes were subjected to hypoxia and reoxygenation.
  • Apoptosis was quantified using TUNEL and annexin V assays.
  • Intact rat hearts underwent regional ischemia and reperfusion, with TGF-beta1 administration during reperfusion.
  • The p42/p44 MAPK pathway was inhibited using PD98059.

Main Results:

  • TGF-beta1 significantly attenuated cell membrane damage and reduced apoptosis in myocytes during reoxygenation.
  • The anti-apoptotic effect of TGF-beta1 was blocked by the p42/p44 MAPK inhibitor PD98059.
  • In intact hearts, TGF-beta1 administration during reperfusion markedly reduced infarct size.
  • The infarct-limiting effect of TGF-beta1 was abolished by PD98059, indicating MAPK pathway involvement.

Conclusions:

  • TGF-beta1 effectively mitigates cardiac myocyte apoptosis during early reperfusion.
  • TGF-beta1 limits infarct size in a model of myocardial ischemia-reperfusion injury.
  • The protective mechanisms of TGF-beta1 against cardiac reperfusion injury are dependent on the activation of the p42/p44 MAPK signaling pathway.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...